| ■ 영문 제목 : Global Fill Finish Manufacturing Market 2023-2027 | |
![]() | ■ 상품코드 : IRTNTR75009-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 2월 최신판(2025년 또는 2026년)은 문의주세요. ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (24시간 이내) ■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD2,500 ⇒환산₩3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,600,000 | 견적의뢰/주문/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| Technavio사는 세계의 완제 (Fill Finish) 제조 시장 규모가 2022년과 2027년 사이에 5,774.96백만 달러에 이르며, 예측 기간 동안 연평균 10.22% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 완제 (Fill Finish) 제조 시장에 대해 조사 및 분석을 실시하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 제품별 (소모품, 제조 기기) 분석, 최종 용도별 (수탁 제조 기관, 바이오 의약품 기업) 분석, 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 중동 및 아프리카, 남미, 중국, 미국, 독일, 캐나다, 영국) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 AbbVie Inc., Asymchem Inc., BAUSCH Advanced Technology Group, Becton Dickinson and Co., Biocon Ltd., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, groninger and co. gmbh, IMA Industria Macchine Automatiche Spa 와 같은 기업 정보를 포함하고 있습니다. ・개요 ・시장 현황 ・시장 규모 예측 ・과거 시장 규모 ・Five Force 분석 ・세계의 완제 (Fill Finish) 제조 시장 규모 : 제품별 - 소모품 시장 규모 - 제조 기기의 시장 규모 ・세계의 완제 (Fill Finish) 제조 시장 규모 : 최종 용도별 - 수탁 제조 기관에서 사용하는 완제 (Fill Finish) 제조의 시장 규모 - 바이오 의약품 기업에서 사용하는 완제 (Fill Finish) 제조의 시장 규모 ・지역별 현황 - 북미의 완제 (Fill Finish) 제조 시장 규모 - 유럽의 완제 (Fill Finish) 제조 시장 규모 - 아시아 태평양의 완제 (Fill Finish) 제조 시장 규모 - 기타 지역의 충진 마감 제조 시장 규모 - 중국의 완제 (Fill Finish) 제조 시장 규모 - 미국의 완제 (Fill Finish) 제조 시장 규모 - 독일의 완제 (Fill Finish) 제조 시장 규모 - 캐나다의 완제 (Fill Finish) 제조 시장 규모 - 영국의 완제 (Fill Finish) 제조 시장 규모 ・성장 요인/과제/동향 ・기업 현황 ・기업 분석 Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 완제 (Fill Finish) 제조 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 완제 (Fill Finish) 제조 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
Technavio는 2023-2027년 동안의 글로벌 필 핀시 제조 시장을 모니터링하고 있으며, 2022-2027년 동안 시장 규모가 57억 7,496만 달러 증가할 것으로 예상하고, 이 기간 동안 연평균 성장률(CAGR)은 10.22%에 이를 것으로 보고 있습니다. 이 보고서는 필 핀시 제조 시장에 대한 포괄적인 분석, 시장 규모 및 예측, 트렌드, 성장 동력 및 도전 과제를 포함하고 있으며, 약 25개 공급업체에 대한 분석도 제공합니다.
현재 시장 상황, 최신 트렌드 및 동향, 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 필 핀시 제조 시장의 성장은 CDMO(계약 개발 및 제조 조직)의 분석 활용 증가, 하드웨어 관련 문제 개선, 고객 지원 서비스 향상에 의해 주도되고 있습니다.
이 보고서는 필 핀시 제조 시장을 제품, 최종 사용자 및 지역에 따라 세분화합니다. 제품별로는 소모품과 기기로 나뉘며, 최종 사용자로는 계약 제조 조직과 생물 제약 회사가 포함됩니다. 지역적으로는 아시아, 북미, 유럽 및 기타 지역(ROW)으로 나뉩니다.
자동화의 증가하는 채택이 필 핀시 제조 시장 성장의 주요 요인 중 하나로 확인되었으며, 생물 제약 산업의 성장과 필 핀시 제조에 대한 아웃소싱 서비스의 증가도 시장 수요를 크게 증가시킬 것입니다.
Technavio는 데이터 수집 및 분석을 통해 시장의 상세한 그림을 제시하며, 필 핀시 제조 시장의 규모, 예측 및 산업 분석을 포함합니다. 또한 주요 공급업체에 대한 상세한 분석을 제공하여 고객이 시장에서의 위치를 개선할 수 있도록 돕고 있습니다. 주요 공급업체로는 AbbVie Inc., Asymchem Inc., BAUSCH Advanced Technology Group, Becton Dickinson and Co., Biocon Ltd., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, groninger and co. gmbh, IMA Industria Macchine Automatiche Spa, Maquinaria Industrial Dara SL, Merck KGaA, Nipro Pharma Packaging International NV, OPTIMA packaging group GmbH, Recipharm AB, SCHOTT AG, Syntegon Technology GmbH, Thermo Fisher Scientific Inc., Vetter Pharma Fertigung GmbH and Co. KG, West Pharmaceutical Services Inc., WuXi Biologics Cayman Inc. 등이 포함됩니다.
이 보고서는 시장 성장에 영향을 미칠 향후 트렌드와 도전 과제에 대한 정보도 포함되어 있어 기업들이 향후 성장 기회를 전략적으로 활용할 수 있도록 돕습니다. 이 연구는 주요 산업 참가자들의 정보를 포함한 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 보고서에는 포괄적인 시장 및 공급업체 환경과 주요 공급업체 분석도 포함되어 있습니다.
Technavio는 수익, 가격, 경쟁 및 프로모션과 같은 주요 매개변수 분석을 통해 시장의 상세한 그림을 제시하며, 주요 산업 영향력을 식별하여 다양한 시장 측면을 제시합니다. 제공되는 데이터는 포괄적이고 신뢰할 수 있으며, 광범위한 연구의 결과입니다. Technavio의 시장 조사 보고서는 완전한 경쟁 환경과 심층적인 공급업체 선정 방법론 및 분석을 통해 정확한 시장 성장 예측을 제공합니다.
■ 보고서 목차• 1 요약 • 3 시장 규모 o 3.4 시장 전망: 2022-2027년 예측 o 표 38: 계측기 차트 – 2022-2027년 시장 규모 및 전망 (백만 달러) o 표 52: 바이오제약 회사 현황 – 2022-2027년 시장 규모 및 전망 (백만 달러) (백만 달러) (백만 달러) o 9.2 지역별 비교 o 9.3 아시아 – 시장 규모 및 전망 2022-2027 o 표 71: 유럽 시장 규모 및 전망 차트 2022-2027 (백만 달러) o 표 75: 기타 지역(ROW) 시장 규모 및 전망 차트 2022-2027 (백만 달러) o 표 79: 중국 – 시장 규모 및 전망 2022-2027 (백만 달러) 차트 o 표 91: 캐나다 차트 – 2022-2027년 시장 규모 및 전망(백만 달러) o 표 95: 영국 차트 – 시장 규모 및 전망 2022-2027년 (백만 달러) • 11 공급업체 시장 현황 o 표 118: 바이오콘 앤 컴퍼니 – 주요 제품 및 서비스 o 표 127: 게레스하이머 AG – 주요 뉴스 첨부 자료: 표 1: 요약 – 시장 개요 차트 첨부자료 17: 글로벌 시장: 전년 대비 성장률 2022-2027 (%) 데이터 표 o 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market by Geography o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global fill finish manufacturing market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on Global fill finish manufacturing market 2017 - 2021 ($ million) o 4.2 Product Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million) o 4.3 End-user Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Product o 6.1 Market segments o Exhibit 30: Chart on Product - Market share 2022-2027 (%) o Exhibit 31: Data Table on Product - Market share 2022-2027 (%) o 6.2 Comparison by Product o Exhibit 32: Chart on Comparison by Product o Exhibit 33: Data Table on Comparison by Product o 6.3 Consumables - Market size and forecast 2022-2027 o Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%) o 6.4 Instruments - Market size and forecast 2022-2027 o Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%) o 6.5 Market opportunity by Product o Exhibit 42: Market opportunity by Product ($ million) o Exhibit 43: Data Table on Market opportunity by Product ($ million) • 7 Market Segmentation by End-user o 7.1 Market segments o Exhibit 44: Chart on End-user - Market share 2022-2027 (%) o Exhibit 45: Data Table on End-user - Market share 2022-2027 (%) o 7.2 Comparison by End-user o Exhibit 46: Chart on Comparison by End-user o Exhibit 47: Data Table on Comparison by End-user o 7.3 Contract manufacturing organizations - Market size and forecast 2022-2027 o Exhibit 48: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million) o Exhibit 49: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million) o Exhibit 50: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%) o Exhibit 51: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%) o 7.4 Biopharmaceutical companies - Market size and forecast 2022-2027 o Exhibit 52: Chart on Biopharmaceutical companies - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Data Table on Biopharmaceutical companies - Market size and forecast 2022-2027 ($ million) o Exhibit 54: Chart on Biopharmaceutical companies - Year-over-year growth 2022-2027 (%) o Exhibit 55: Data Table on Biopharmaceutical companies - Year-over-year growth 2022-2027 (%) o 7.5 Market opportunity by End-user o Exhibit 56: Market opportunity by End-user ($ million) o Exhibit 57: Data Table on Market opportunity by End-user ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 59: Chart on Market share by geography 2022-2027 (%) o Exhibit 60: Data Table on Market share by geography 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 61: Chart on Geographic comparison o Exhibit 62: Data Table on Geographic comparison o 9.3 Asia - Market size and forecast 2022-2027 o Exhibit 63: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 64: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 65: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 66: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.4 North America - Market size and forecast 2022-2027 o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.5 Europe - Market size and forecast 2022-2027 o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 China - Market size and forecast 2022-2027 o Exhibit 79: Chart on China - Market size and forecast 2022-2027 ($ million) o Exhibit 80: Data Table on China - Market size and forecast 2022-2027 ($ million) o Exhibit 81: Chart on China - Year-over-year growth 2022-2027 (%) o Exhibit 82: Data Table on China - Year-over-year growth 2022-2027 (%) o 9.8 US - Market size and forecast 2022-2027 o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.9 Germany - Market size and forecast 2022-2027 o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.10 Canada - Market size and forecast 2022-2027 o Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%) o Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%) o 9.11 UK - Market size and forecast 2022-2027 o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity by geography o Exhibit 99: Market opportunity by geography ($ million) o Exhibit 100: Data Tables on Market opportunity by geography ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 101: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 103: Overview on factors of disruption o 11.4 Industry risks o Exhibit 104: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 105: Vendors covered o 12.2 Market positioning of vendors o Exhibit 106: Matrix on vendor position and classification o 12.3 AbbVie Inc. o Exhibit 107: AbbVie Inc. - Overview o Exhibit 108: AbbVie Inc. - Product / Service o Exhibit 109: AbbVie Inc. - Key news o Exhibit 110: AbbVie Inc. - Key offerings o 12.4 Becton Dickinson and Co. o Exhibit 111: Becton Dickinson and Co. - Overview o Exhibit 112: Becton Dickinson and Co. - Business segments o Exhibit 113: Becton Dickinson and Co. - Key news o Exhibit 114: Becton Dickinson and Co. - Key offerings o Exhibit 115: Becton Dickinson and Co. - Segment focus o 12.5 Biocon Ltd. o Exhibit 116: Biocon Ltd. - Overview o Exhibit 117: Biocon Ltd. - Business segments o Exhibit 118: Biocon Ltd. - Key offerings o Exhibit 119: Biocon Ltd. - Segment focus o 12.6 Fresenius SE and Co. KGaA o Exhibit 120: Fresenius SE and Co. KGaA - Overview o Exhibit 121: Fresenius SE and Co. KGaA - Business segments o Exhibit 122: Fresenius SE and Co. KGaA - Key news o Exhibit 123: Fresenius SE and Co. KGaA - Key offerings o Exhibit 124: Fresenius SE and Co. KGaA - Segment focus o 12.7 Gerresheimer AG o Exhibit 125: Gerresheimer AG - Overview o Exhibit 126: Gerresheimer AG - Business segments o Exhibit 127: Gerresheimer AG - Key news o Exhibit 128: Gerresheimer AG - Key offerings o Exhibit 129: Gerresheimer AG - Segment focus o 12.8 groninger and co. gmbh o Exhibit 130: groninger and co. gmbh - Overview o Exhibit 131: groninger and co. gmbh - Product / Service o Exhibit 132: groninger and co. gmbh - Key offerings o 12.9 IMA Industria Macchine Automatiche Spa o Exhibit 133: IMA Industria Macchine Automatiche Spa - Overview o Exhibit 134: IMA Industria Macchine Automatiche Spa - Business segments o Exhibit 135: IMA Industria Macchine Automatiche Spa - Key news o Exhibit 136: IMA Industria Macchine Automatiche Spa - Key offerings o Exhibit 137: IMA Industria Macchine Automatiche Spa - Segment focus o 12.10 Maquinaria Industrial Dara SL o Exhibit 138: Maquinaria Industrial Dara SL - Overview o Exhibit 139: Maquinaria Industrial Dara SL - Product / Service o Exhibit 140: Maquinaria Industrial Dara SL - Key offerings o 12.11 Merck KGaA o Exhibit 141: Merck KGaA - Overview o Exhibit 142: Merck KGaA - Business segments o Exhibit 143: Merck KGaA - Key news o Exhibit 144: Merck KGaA - Key offerings o Exhibit 145: Merck KGaA - Segment focus o 12.12 Nipro Pharma Packaging International NV o Exhibit 146: Nipro Pharma Packaging International NV - Overview o Exhibit 147: Nipro Pharma Packaging International NV - Business segments o Exhibit 148: Nipro Pharma Packaging International NV - Key news o Exhibit 149: Nipro Pharma Packaging International NV - Key offerings o Exhibit 150: Nipro Pharma Packaging International NV - Segment focus o 12.13 OPTIMA packaging group GmbH o Exhibit 151: OPTIMA packaging group GmbH - Overview o Exhibit 152: OPTIMA packaging group GmbH - Product / Service o Exhibit 153: OPTIMA packaging group GmbH - Key offerings o 12.14 Recipharm AB o Exhibit 154: Recipharm AB - Overview o Exhibit 155: Recipharm AB - Business segments o Exhibit 156: Recipharm AB - Key offerings o Exhibit 157: Recipharm AB - Segment focus o 12.15 SCHOTT AG o Exhibit 158: SCHOTT AG - Overview o Exhibit 159: SCHOTT AG - Business segments o Exhibit 160: SCHOTT AG - Key news o Exhibit 161: SCHOTT AG - Key offerings o Exhibit 162: SCHOTT AG - Segment focus o 12.16 Syntegon Technology GmbH o Exhibit 163: Syntegon Technology GmbH - Overview o Exhibit 164: Syntegon Technology GmbH - Product / Service o Exhibit 165: Syntegon Technology GmbH - Key offerings o 12.17 Thermo Fisher Scientific Inc. o Exhibit 166: Thermo Fisher Scientific Inc. - Overview o Exhibit 167: Thermo Fisher Scientific Inc. - Business segments o Exhibit 168: Thermo Fisher Scientific Inc. - Key news o Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings o Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 171: Inclusions checklist o Exhibit 172: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 173: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 174: Research methodology o Exhibit 175: Validation techniques employed for market sizing o Exhibit 176: Information sources o 13.5 List of abbreviations o Exhibit 177: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by End-user Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on Global fill finish manufacturing market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Product - Market share 2022-2027 (%) Exhibits31: Data Table on Product - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Product Exhibits33: Data Table on Comparison by Product Exhibits34: Chart on Consumables - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Consumables - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Consumables - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%) Exhibits42: Market opportunity by Product ($ million) Exhibits43: Data Table on Market opportunity by Product ($ million) Exhibits44: Chart on End-user - Market share 2022-2027 (%) Exhibits45: Data Table on End-user - Market share 2022-2027 (%) Exhibits46: Chart on Comparison by End-user Exhibits47: Data Table on Comparison by End-user Exhibits48: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million) Exhibits49: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million) Exhibits50: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%) Exhibits51: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%) Exhibits52: Chart on Biopharmaceutical companies - Market size and forecast 2022-2027 ($ million) Exhibits53: Data Table on Biopharmaceutical companies - Market size and forecast 2022-2027 ($ million) Exhibits54: Chart on Biopharmaceutical companies - Year-over-year growth 2022-2027 (%) Exhibits55: Data Table on Biopharmaceutical companies - Year-over-year growth 2022-2027 (%) Exhibits56: Market opportunity by End-user ($ million) Exhibits57: Data Table on Market opportunity by End-user ($ million) Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits59: Chart on Market share by geography 2022-2027 (%) Exhibits60: Data Table on Market share by geography 2022-2027 (%) Exhibits61: Chart on Geographic comparison Exhibits62: Data Table on Geographic comparison Exhibits63: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits64: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits65: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits66: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits79: Chart on China - Market size and forecast 2022-2027 ($ million) Exhibits80: Data Table on China - Market size and forecast 2022-2027 ($ million) Exhibits81: Chart on China - Year-over-year growth 2022-2027 (%) Exhibits82: Data Table on China - Year-over-year growth 2022-2027 (%) Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%) Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits99: Market opportunity by geography ($ million) Exhibits100: Data Tables on Market opportunity by geography ($ million) Exhibits101: Impact of drivers and challenges in 2022 and 2027 Exhibits102: Overview on Criticality of inputs and Factors of differentiation Exhibits103: Overview on factors of disruption Exhibits104: Impact of key risks on business Exhibits105: Vendors covered Exhibits106: Matrix on vendor position and classification Exhibits107: AbbVie Inc. - Overview Exhibits108: AbbVie Inc. - Product / Service Exhibits109: AbbVie Inc. - Key news Exhibits110: AbbVie Inc. - Key offerings Exhibits111: Becton Dickinson and Co. - Overview Exhibits112: Becton Dickinson and Co. - Business segments Exhibits113: Becton Dickinson and Co. - Key news Exhibits114: Becton Dickinson and Co. - Key offerings Exhibits115: Becton Dickinson and Co. - Segment focus Exhibits116: Biocon Ltd. - Overview Exhibits117: Biocon Ltd. - Business segments Exhibits118: Biocon Ltd. - Key offerings Exhibits119: Biocon Ltd. - Segment focus Exhibits120: Fresenius SE and Co. KGaA - Overview Exhibits121: Fresenius SE and Co. KGaA - Business segments Exhibits122: Fresenius SE and Co. KGaA - Key news Exhibits123: Fresenius SE and Co. KGaA - Key offerings Exhibits124: Fresenius SE and Co. KGaA - Segment focus Exhibits125: Gerresheimer AG - Overview Exhibits126: Gerresheimer AG - Business segments Exhibits127: Gerresheimer AG - Key news Exhibits128: Gerresheimer AG - Key offerings Exhibits129: Gerresheimer AG - Segment focus Exhibits130: groninger and co. gmbh - Overview Exhibits131: groninger and co. gmbh - Product / Service Exhibits132: groninger and co. gmbh - Key offerings Exhibits133: IMA Industria Macchine Automatiche Spa - Overview Exhibits134: IMA Industria Macchine Automatiche Spa - Business segments Exhibits135: IMA Industria Macchine Automatiche Spa - Key news Exhibits136: IMA Industria Macchine Automatiche Spa - Key offerings Exhibits137: IMA Industria Macchine Automatiche Spa - Segment focus Exhibits138: Maquinaria Industrial Dara SL - Overview Exhibits139: Maquinaria Industrial Dara SL - Product / Service Exhibits140: Maquinaria Industrial Dara SL - Key offerings Exhibits141: Merck KGaA - Overview Exhibits142: Merck KGaA - Business segments Exhibits143: Merck KGaA - Key news Exhibits144: Merck KGaA - Key offerings Exhibits145: Merck KGaA - Segment focus Exhibits146: Nipro Pharma Packaging International NV - Overview Exhibits147: Nipro Pharma Packaging International NV - Business segments Exhibits148: Nipro Pharma Packaging International NV - Key news Exhibits149: Nipro Pharma Packaging International NV - Key offerings Exhibits150: Nipro Pharma Packaging International NV - Segment focus Exhibits151: OPTIMA packaging group GmbH - Overview Exhibits152: OPTIMA packaging group GmbH - Product / Service Exhibits153: OPTIMA packaging group GmbH - Key offerings Exhibits154: Recipharm AB - Overview Exhibits155: Recipharm AB - Business segments Exhibits156: Recipharm AB - Key offerings Exhibits157: Recipharm AB - Segment focus Exhibits158: SCHOTT AG - Overview Exhibits159: SCHOTT AG - Business segments Exhibits160: SCHOTT AG - Key news Exhibits161: SCHOTT AG - Key offerings Exhibits162: SCHOTT AG - Segment focus Exhibits163: Syntegon Technology GmbH - Overview Exhibits164: Syntegon Technology GmbH - Product / Service Exhibits165: Syntegon Technology GmbH - Key offerings Exhibits166: Thermo Fisher Scientific Inc. - Overview Exhibits167: Thermo Fisher Scientific Inc. - Business segments Exhibits168: Thermo Fisher Scientific Inc. - Key news Exhibits169: Thermo Fisher Scientific Inc. - Key offerings Exhibits170: Thermo Fisher Scientific Inc. - Segment focus Exhibits171: Inclusions checklist Exhibits172: Exclusions checklist Exhibits173: Currency conversion rates for US$ Exhibits174: Research methodology Exhibits175: Validation techniques employed for market sizing Exhibits176: Information sources Exhibits177: List of abbreviations |
| ※참고 정보 완제(Fill Finish) 제조는 제약 및 바이오제약 산업에서 중요한 과정으로, 최종 제품인 의약품이나 백신을 용기나 주사기에 충전하고 밀봉하는 단계를 포함합니다. 이 과정은 일반적으로 제형을 제조한 후 마지막으로 수행되는 단계로, 제품의 품질과 안전성을 보장하는 데 매우 중요한 역할을 합니다. 완제 제조는 고도의 기술과 장비가 필요한 과정으로, 무균 환경에서 진행되며, 다양한 품질 관리 절차를 따릅니다. 완제 제조의 주요 개념은 제품의 물리적, 화학적, 미생물학적 안정성을 보장하는 것입니다. 이 과정에서 용기에 담기는 제품은 주사제, 정제, 액상 제제 등 다양하며, 각각의 제형에 따라 충전 및 밀봉 방식이 다르게 적용됩니다. 또한, 완제 제조는 생산된 의약품이 실제로 환자에게 전달될 수 있도록 하는 최종 단계이기 때문에, 이러한 과정의 오류는 환자에게 심각한 결과를 초래할 수 있습니다. 완제 제조의 종류는 여러 가지로 구분할 수 있습니다. 먼저, 액체 제형은 주사 가능한 용액이나 분산 형태로, 다양한 약물이 포함될 수 있습니다. 고형 제형으로는 정제가 있으며, 이는 주로 알약 형태로 제공됩니다. 또한, 펠렛, 캡슐, 또는 분말 형태로도 출시될 수 있습니다. 주사 가능한 솔루션 외에도, 에어로졸, 크림, 연고 등과 같은 외용 제형이 있습니다. 각 제형의 특성과 요구 사항에 따라 충전 및 밀봉 기술이 다르게 사용됩니다. 완제 제조의 주요 용도는 환자를 위한 안전하고 효과적인 약물을 제공하는 것입니다. 이 과정에서 최종 제품은 다양한 형태로 환자에게 전달되며, 치료 효과를 극대화할 수 있는 방식으로 설계됩니다. 제약 회사들은 완제 제조의 품질을 보장하기 위해 엄격한 규제 기준을 준수해야 하며, 이는 FDA, EMA 등의 국제 규제 기관이 제정한 가이드라인에 따라 달라집니다. 이러한 규제는 완제 제품의 품질, 안전성, 효능을 보장하기 위한 것입니다. 완제 제조와 관련된 기술은 다양한 자동화 기계와 장비, 무균 생산 환경을 포함합니다. 현대의 완제 제조 공정은 컴퓨터화된 시스템을 통해 모니터링되고, 자동화된 시스템이 웬만한 작업을 수행하여 인적 오류를 줄입니다. 또한, 무균 환경을 유지하기 위해 클린룸과 같은 특수한 제조 시설이 필요하고, 이곳에서는 공기 질과 온도, 습도 등이 엄격히 통제됩니다. 또한, 완제 제조의 품질 관리 시스템(QMS)은 제품이 규격에 맞는지 확인하고, 모든 제조 공정이 규제 기준을 준수하도록 관리합니다. 이러한 시스템은 제조 소프트웨어를 통해 실시간으로 데이터를 수집하고 분석함으로써, 공정의 지속적인 개선과 최적 작업 조건을 유지하는 데 기여합니다. 완제 제조는 소비자와 환자에게 안전하고 효과적인 의약품을 제공하는 중요한 기반이 됩니다. 따라서, 생명 과학 분야에서 지속적인 기술 발전과 혁신이 이루어져야 하며, 새로운 제형 개발, 제조 공정의 효율성을 높이고, 품질 관리를 강화하는 노력이 계속되어야 합니다. 이는 궁극적으로 헬스케어 산업의 발전과 환자의 건강 증진에 기여하게 됩니다. |
| ※본 조사보고서 [세계의 완제 (Fill Finish) 제조 시장 (2023년~2027년)] (코드 : IRTNTR75009-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 완제 (Fill Finish) 제조 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |

